The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive plasma proteomic biomarkers of immunotherapy toxicity in patients (pts) with metastatic melanoma (MM).
 
Meghan Mooradian
No Relationships to Disclose
 
Xuesong Gu
No Relationships to Disclose
 
Donald P. Lawrence
No Relationships to Disclose
 
Justine Vanessa Cohen
No Relationships to Disclose
 
Tatyana Sharova
No Relationships to Disclose
 
Genevieve Marie Boland
No Relationships to Disclose
 
Towia A. Libermann
Employment - Nichi-iko (I)
Leadership - Nichi-iko (I)
Stock and Other Ownership Interests - Anxome; BiomaRx Therapeutics; Nichi-iko (I)
Patents, Royalties, Other Intellectual Property - Receiving royalty for diagnostic biomarker test for transplant rejection from Quest
 
Ryan J. Sullivan
Honoraria - Roche/Genentech
Consulting or Advisory Role - ACI Clinical; Amgen; Array BioPharma; Biodesix; BiolineRx; Merck; Novartis; Takeda; WorldCare Clinical, LLC
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Other Relationship - Boehringer Ingelheim